HOUSTON, Aug. 28, 2025 (GLOBE NEWSWIRE) -- Moleculin Biotech, Inc., (Nasdaq: MBRX) (“Moleculin” or the “Company”), a late-stage pharmaceutical company…
Generic Saxenda® is the first-ever generic GLP-1 indicated for weight loss, addressing increased demand for this category of therapies in…
NEEDHAM, Mass., Aug. 28, 2025 (GLOBE NEWSWIRE) -- Candel Therapeutics, Inc. (Candel or the Company) (Nasdaq: CADL), a clinical-stage biopharmaceutical…
RANCHO CUCAMONGA, CA / ACCESS Newswire / August 28, 2025 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced today that Bill Peters,…
CAMBRIDGE, MA / ACCESS Newswire / August 27, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that the U.S. Food and…
SHENZHEN, China, Aug. 27, 2025 /PRNewswire/ -- Key Highlights from the Financial Report: Revenue surged 404% year over year to…
In this free webinar, gain an overview of common formulation challenges in global pharmaceutical development, particularly for APIs with poor…
In this free webinar, gain insight into rapid, reliable analytics for evolving mRNA modalities. Attendees will learn about mRNA modality-specific CQA…
Updates include AI-enabled EHR interoperability, comprehensive data collection, and safety integration capabilities AUSTIN, Texas, Aug. 27, 2025 /PRNewswire/ -- Oracle today…
New GlidePRO™ offers crown-down planning, personalized support and same-day provisionalization to support All-on-X procedures. IRVINE, CALIFORNIA / ACCESS Newswire /…